Professional
Added to YB: 2024-05-29
Pitch date: 2024-04-23
PFE [bullish]
Pfizer Inc.
+14.54%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Market Cap
$148.0B
Pitch Price
$22.66
Price Target
N/A
Dividend
6.63%
EV/EBITDA
7.58
P/E
19.81
EV/Sales
3.16
Sector
Pharmaceuticals
Category
turnaround
Show full summary:
Parnassus Value Equity Fund New Position: Pfizer Inc.
PFE -40% in '23 on COVID vax sales slump. Seagen acq bolsters ADC pipeline. Compelling entry point w/ strong dividend yield for potential turnaround play post-COVID boom/bust cycle.
Read full article (1 min)